Key result
Macrophage CARS2 suppression triggers a pro-inflammatory interferon-like response and lowers NF-κB activity and ROS.
CARS2 suppression in THP-1 macrophages induces a pro-inflammatory signature independent of its canonical mitochondrial role, providing mechanistic insight into its association with coronary artery disease.
Answers are grounded in this paper and cite their sources.
CARS2 modulation may influence macrophage inflammation; leaves open its therapeutic relevance in human CAD.
Genome-wide association studies have linked CARS2 locus, encoding the mitochondrial cysteinyl aminoacyl-tRNA synthetase CARS2, to coronary artery disease. Moreover, we previously demonstrated that CARS2 suppression was associated with a pro-inflammatory expression profile in cell models. However, the mechanisms were largely unexplored. Here, we further examine the changes associated with CARS2 suppression through bioinformatic and experimental approaches. Analysis of transcriptomic data from CARS2- suppressed cells revealed the prominent establishment of an interferon-like response in unpolarized THP-1 macrophages, as well as possible NF-ΚB activation. This was not accompanied by significant activation of STAT1 or NF-ΚB phosphorylation, indicative of interferon pathway activation and NF-ΚB activity, respectively. Rather, an NF-ΚB activity reporter THP-1 model revealed that NF-ΚB activation was modestly diminished in CARS2 -suppressed cells. Furthermore, suppression of CARS2 , or a YARS2 control, similarly reduced radical oxygen species levels without affecting mitochondrial content or membrane potential. However, YARS2 suppression was not pro-inflammatory, suggesting that reduced ROS levels are insufficient to explain the CARS2 effect. Finally, reduced CARS2 levels did not alter the abundance of respiratory complexes or mitochondrial function. These results argue for an anti-inflammatory contribution of CARS2 in THP-1-derived macrophages, which extends beyond its canonical mitochondrial role.
No takes yet. Share an insight, caveat, or question.
Dang et al. (2026) studied Inflammation and Coronary Artery Disease (in vitro model). CARS2 suppression via siRNA vs. Non-target siRNA (NT2) or YARS2 suppression was evaluated on Transcriptomic changes, inflammatory signaling, and mitochondrial function. Reduced CARS2 expression in THP-1 macrophages elicited a pro-inflammatory interferon-like response and reduced NF-κB activity and reactive oxygen species levels, without causing detectable mitochondrial dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: